Privi Speciality Chemicals Limited (PRIVISCL) AI Stock Analysis

• Market Cap: ₹94.99B
• Dividend Yield: 0.21%
• Average Volume (3M): 9.44K
• Price to Earnings (P/E): 43.7
• Beta (1Y): 0.65
• Revenue Growth: 21.50%
• EPS Growth: 78.82%
• Country: IN
• Employees: 711
• Sector: Basic Materials
• Sector Strength: 60
• Industry: Chemicals - Specialty
• EPS (TTM): 15.85
• Shares Outstanding: 39,062,702
• 10 Day Avg. Volume: 15,886
• 30 Day Avg. Volume: 9,436
• PEG Ratio: 0.38
• Price to Book (P/B): 6.33
• Price to Sales (P/S): 3.32
• P/FCF Ratio: -387.29
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹2,709.00
• Price Target Upside: 11.73% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 66 Neutral
• Price Target: ₹2,709.00 ▲(11.73% Upside)

Privi Speciality Chemicals Limited has a strong financial performance with robust revenue growth and profitability. The technical analysis indicates a positive trend, though the valuation suggests the stock may be overvalued. The absence of earnings call and corporate events data means these factors do not influence the score.

Privi Speciality Chemicals Limited Business Overview & Revenue Model

Company Description

Privi Speciality Chemicals Limited (PRIVISCL) is a leading manufacturer and supplier of aroma and fragrance chemicals. The company operates within the chemical industry, focusing on the production of high-quality specialty chemicals which are essential components in the creation of fragrances. These chemicals are used in a variety of applications including perfumes, cosmetics, soaps, and detergents. The company is known for its robust research and development capabilities, which enable it to innovate and provide customized solutions to its clients globally.

How the Company Makes Money

Privi Speciality Chemicals Limited generates revenue primarily through the manufacture and sale of aroma and fragrance chemicals. The company's key revenue streams include direct sales to fragrance manufacturers, partnerships with consumer goods companies, and long-term supply agreements with major players in the personal care and household products industries. Privi's focus on research and development allows it to create specialized compounds that command higher value, thus contributing to its profitability. Additionally, the company may engage in strategic collaborations or joint ventures to expand its market reach and enhance its product portfolio, further driving its revenue growth.

Privi Speciality Chemicals Limited Financial Statement Overview

Summary

Privi Speciality Chemicals Limited exhibits strong revenue growth and improving profitability, supported by effective cost management and operational efficiency. The balance sheet is solid with reasonable leverage and a stable equity position. However, the negative free cash flow due to high capital expenditures poses a risk to liquidity, requiring careful management to sustain growth and investment.

Income Statement

Privi Speciality Chemicals Limited has demonstrated a robust revenue growth rate of 19.9% from 2024 to 2025, indicating strong demand and expansion. The gross profit margin stands at a healthy 38.9%, and the net profit margin improved to 8.9% in 2025, reflecting enhanced profitability. However, the EBIT margin is notably high at 34.7%, suggesting significant operational efficiency. EBITDA margin has decreased from the previous year but remains substantial at 21.4%. Overall, the company shows positive growth and profitability trends.

Balance Sheet

The debt-to-equity ratio is 1.04, showing a balanced leverage position, while the return on equity (ROE) improved to 16.9% in 2025, indicating effective utilization of equity capital. The equity ratio is stable at 39.5%, reflecting a sound capital structure. Despite a slight increase in debt levels, the company maintains a managed balance sheet with adequate equity backing its assets.

Cash Flow

Operating cash flow to net income ratio is 1.50, indicating strong cash generation relative to net earnings. However, the free cash flow has turned negative in 2025, primarily due to capital expenditures exceeding operating cash flows. The free cash flow to net income ratio is negative, highlighting potential liquidity constraints. Although operating cash flows are robust, the significant outflow for capital investments is a concern for free cash flow sustainability.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	21.01B	21.01B	16.08B	17.52B	14.02B	12.68B
Gross Profit	7.49B	8.16B	5.00B	3.37B	5.61B	5.04B
EBITDA	4.56B	4.49B	2.09B	3.54B	2.33B	2.52B
Net Income	1.87B	1.87B	222.15M	949.07M	973.80M	1.17B
Balance Sheet
Total Assets	27.91B	27.91B	23.91B	23.43B	21.76B	15.40B
Cash, Cash Equivalents and Short-Term Investments	577.31M	577.31M	318.17M	635.46M	445.19M	154.53M
Total Debt	11.43B	11.43B	10.79B	10.08B	9.30B	5.37B
Total Liabilities	16.73B	16.73B	15.56B	14.01B	13.56B	8.18B
Stockholders Equity	11.03B	11.03B	8.29B	9.24B	8.12B	7.23B
Cash Flow
Free Cash Flow	0.00	-180.27M	-909.33M	2.04B	-3.04B	-706.96M
Operating Cash Flow	0.00	2.81B	487.59M	3.54B	47.36M	1.72B
Investing Cash Flow	0.00	-2.94B	-1.33B	-1.80B	-3.20B	-2.42B
Financing Cash Flow	0.00	386.33M	723.05M	-1.71B	3.33B	1.55M

Privi Speciality Chemicals Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2424.65
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PRIVISCL, the sentiment is Positive. The current price of 2424.65 is below the 20-day moving average (MA) of 2450.69, above the 50-day MA of 2403.22, and above the 200-day MA of 1960.70, indicating a neutral trend. The MACD of 17.04 indicates Positive momentum. The RSI at 49.95 is Neutral, neither overbought nor oversold. The STOCH value of 58.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:PRIVISCL.

Privi Speciality Chemicals Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FCL	72 Outperform	₹26.12B	23.92		0.35%	-8.66%	-17.63%
NCC	72 Outperform	₹139.92B	17.44		0.99%	-0.65%	7.37%
Sector *	70 Outperform	¥179.17B	11.24	5.69%	3.09%	2.75%	-12.76%
ALKYLAMINE	69 Neutral	₹106.27B	57.09		0.48%	9.11%	24.90%
PRIVISCL	66 Neutral	₹94.99B	43.66		0.21%	21.50%	78.82%
ACI	62 Neutral	₹80.47B	51.10		0.65%	-6.59%	-41.72%
SUDARSCHEM	52 Neutral	₹113.13B	63.99		0.32%	31.78%	-84.27%

Privi Speciality Chemicals Limited Corporate Events

Privi Speciality Chemicals Declares No Share Encumbrances for FY 2025

Privi Speciality Chemicals Limited has announced that there were no encumbrances made on its equity shares by the promoter group during the financial year ending March 31, 2025. This disclosure under SEBI regulations ensures transparency and may positively impact stakeholder confidence, reinforcing the company’s stable financial positioning within the industry.